COLUMBUS, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NAVB) (“Navidea” or the “Company”) today announced that its Board of Directors has elected to extend the Company’s Section 382 ...
DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results